NEWSROOM

PRESS RELEASE

Universal Media Group Inc. (UMGP) wins Suncoast Emmy Award

Universal Media Group Inc. (UMGP) wins Suncoast Emmy Award

Dec 10, 2024

BOCA RATON, Fla., Dec. 10, 2024 - PRISM MediaWire - Universal Media Group Inc. (OTC: UMGP) is proud to announce that its Emmy-nominated weekly television show, Before The Fame with Mike Sherman, has won a prestigious Suncoast Emmy Award in the Long Form Content Editing category for its episode featuring pop superstar Shaggy. Page 27 https://youtu.be/Q-6jl0TrNSg This milestone marks a significant achievement for Scott Edward, Director of Editing at Universal Media Group, who has been nominated...

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Dec 9, 2024

January 13-16, 2025, San Francisco, CA IRVINE, Calif., December 9, 2024 - PRISM MediaWire - Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend “J.P. Morgan Week,” coinciding with the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, from January 13 - 16, 2025. During this period, Oncocyte will host one-on-one meetings with interested investors....

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board

Dec 9, 2024

Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of Directors New York, NY, December 9, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer’s and Parkinson’s disease is proud to announce the appointment of Dr. Merit Cudkowicz,...

SKYX to Conduct a Company Presentation at Benchmark Conference on December 11, 2024, at 3:30pm

Dec 9, 2024

Rani Kohen, Founder, and Lenny Sokolow, Co-CEO of SKYX, to Present at 3:30 PM ET on December 11, 2024, and Engage in Investor Meetings Throughout the Conference at the New York Athletic Club MIAMI, December 9, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a mission to make homes and...

BranchOut Food Inc. Signs LOI and receives $250K PO from Leading Ingredient Distributor, Definitive Agreement Targeting $5-6M in 2025 Ingredient Sales

BranchOut Food Inc. Signs LOI and receives $250K PO from Leading Ingredient Distributor, Definitive Agreement Targeting $5-6M in 2025 Ingredient Sales

Dec 6, 2024

Projecting $4.0M in net revenue for Q1 2025—up 170% from the prior year—and expects to achieve positive cash flow in the same quarter Key Highlights: Signed LOI with leading ingredient distributor, establishing immediate sales volume in the ingredient channel. Received an initial $250,000 purchase order alongside the LOI. Anticipating completing a Definitive Agreement in January with a minimum commitment of $5M in sales for 2025. New Peru factory’s three production lines are now fully...

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

Dec 6, 2024

IRVINE, Calif., Dec. 04, 2024 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by measuring somatic copy number aberrations (SCNAs) in cerebrospinal fluid. For context, copy number...

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board

Former Merck USA President Joins Klotho Neurosciences’ Board of Directors

Dec 3, 2024

Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer’s, and Parkinson’s, today announced the appointment of Riad El-Dada, former US President of Merck, to its Board of Directors. With decades of leadership in the pharmaceutical...

AB INTL Group Announces Repurchase of 300 Million Shares and Planning Spin-off of NFT MMM IP and AI Consulting Business

AB INTL Group Announces Repurchase of 300 Million Shares and Planning Spin-off of NFT MMM IP and AI Consulting Business

Dec 3, 2024

NEW YORK, Dec. 03, 2024 - PRISM MediaWire - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced the Company entered into Repurchase Agreements with four shareholders, all non-affiliates of the Company, pursuant to which the Company agreed to repurchase shares of their Common Stock, $0.001 par value, amounting to 300,000,000 shares for cancellation. The price to be paid by the Company under the Repurchase Agreements is...

Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus

Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus

Dec 3, 2024

Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery PITTSBURGH, Dec. 03, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, today announced the publication of a peer-reviewed paper in CUREUS. Titled “Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal...

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms

Dec 2, 2024

Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies Early detection of transplant rejection is growing in significance as novel therapeutic treatments show promising early results in antibody mediated rejection. Study published in Nephrology Dialysis...

Halberd Update on WatchDawg® PTSD Treatment

Halberd Update on WatchDawg® PTSD Treatment

Dec 2, 2024

Next Phase Pilot Study Jackson Center, PA, December 2, 2024 - PRISM MediaWire - Halberd Corporation (OTC PINK: HALB) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation. The results of that study can be found here. Based on the encouraging results of that initial pilot study, upgrades and enhancements to the data collection methodology, data analysis, hardware, software...

StemSation International Announces Acquisition of Gorilla Marketing Group, LLC

StemSation International Announces Acquisition of Gorilla Marketing Group, LLC

Dec 2, 2024

StemSation International announced today the completion of the acquisition of 100% of the private marketing company, Gorilla Marketing Group, LLC Strategic Acquisition Completed: StemSation International has finalized the acquisition of Gorilla Marketing Group (GMG), owner of the high-end AlienHouse vape product line. This move positions the company for significant growth in the THC-P vape and lifestyle product markets. Enhanced Market Presence: With GMG's established brand and innovative...

Skyborne Technology, Inc., a UAV Corp Company (UMAV) and Atlantic Industrial Group Inc. (AIG) Announce AI Manufacturing JV for VTOL & Lighter than Air Vehicles

Skyborne Technology, Inc., a UAV Corp Company (UMAV) and Atlantic Industrial Group Inc. (AIG) Announce AI Manufacturing JV for VTOL & Lighter than Air Vehicles

Dec 2, 2024

Skyborne’s Costin Airport Grant Infrastructure Project Has Been Completed for The Near Future Build of New Hangar Cutting-Edge Manufacturing: AIG will produce high-efficiency drone models (SVTOLs) at Skyborne’s facility, leveraging innovative manufacturing techniques like large-scale 3D printing for airframe parts, wing structures, and cockpits Focus on Design and Innovation: An in-house design center will specialize in creating airships and drones using lightweight materials for superior...

SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

Nov 27, 2024

Rani Kohen, Founder, and Steve Schmidt, President of SKYX, to Present at 1:30 PM ET on December 3, 2024, and Engage in Investor Meetings Throughout the Conference MIAMI, Nov. 27, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe,...

AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

Nov 26, 2024

HAUPPAUGE, N.Y., Nov. 26, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced it has closed on its previously announced registered direct offering for the sale...

ABQQ Reports FY 2024 Audited Financial Results, Introduces FY 2025 Outlook, Announces to Repurchase $5 Million of Shares by Year-End 2025

ABQQ Reports FY 2024 Audited Financial Results, Introduces FY 2025 Outlook, Announces to Repurchase $5 Million of Shares by Year-End 2025

Nov 26, 2024

FY 2024 REVENUE INCREASED 125% TO A RECORD $3.3 MILLION FY 2024 REACH OPERATIONAL PROFITABILITY NET INCOME TO A RECORD $0.54 MILLION GUIDES FY 2025 REVENUE GROWTH OF APPROX. 150%; EPS RANGE OF $0.001 TO $0.002 ANNOUNCES INCREASE TO PREVIOUSLY COMMUNICATED SHARE REPURCHASE GOAL, TO REPURCHASE $5 MILLION OF SHARES BY YEAR END 2025 NEW YORK, Nov. 26, 2024 - PRISM MediaWire - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces...

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

Nov 26, 2024

SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery using its SSi Mantra Surgical Robotic System. Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations successfully performed the first Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) in Indonesia, a significant achievement in the field of robotic cardiac surgery. The developed and made-in-India SSi Mantra Surgical Robotic System highlights India’s position as...

EzFill Signs Definitive Agreement for the Purchase of Yoshi Mobility’s Fuel Division

EzFill Signs Definitive Agreement for the Purchase of Yoshi Mobility’s Fuel Division

Nov 25, 2024

Agreement Expands EzFill’s Operations to Four New States Deal Expected to Close December 2 Miami, FL, November 25, 2024 - PRISM MediaWire - EzFill Holdings Inc. (NASDAQ: EZFL), a leading mobile fueling company, has signed a definitive agreement to acquire the fueling division of Yoshi, Inc. with the aim of expanding its U.S operations and presence. Under the terms of the agreement, EzFill will acquire Yoshi Mobility’s existing mobile fuel service assets and allows EzFill to begin operations...

AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group Announces Pricing of $1.4 Million Registered Direct Offering, Priced At-The-Market

Nov 25, 2024

HAUPPAUGE, N.Y., Nov. 25, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with certain...

Paradigm Oil & Gas, Inc. (PDGO) Reflects on a Transformative 2024, Poised for Continued Growth in 2025

Paradigm Oil & Gas, Inc. (PDGO) Reflects on a Transformative 2024, Poised for Continued Growth in 2025

Nov 25, 2024

NEW YORK, Nov. 25, 2024 - PRISM MediaWire - 2024 has been a pivotal year for Paradigm Oil & Gas, Inc. (OTC: PDGO) (“PDGO”), marked by strategic decisions, focused expansion efforts, and enhanced communication initiatives. As the company continues solidifying its position in the market, it remains committed to fostering growth and creating value for its investors. Market Expansion: The company strategically streamlined its initiatives, discontinuing ventures with uncertain returns while...

BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts

BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts

Nov 25, 2024

Company continues to advance its placental-derived product portfolio with the first patent granted in the fenestrated wound care market POMPANO BEACH, Fla., Nov. 25, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for...

SPZI: JP3E Commenced Initial Shipment for Sugar Commodity Contract

SPZI: JP3E Commenced Initial Shipment for Sugar Commodity Contract

Nov 21, 2024

New Jersey, November 21, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), through its wholly-owned subsidiary, JP Energy Global, PTE, LTD, successfully shipped 300 metric tons of ICUMSA 45 Sugar to the purchaser per contract. This initial sugar delivery triggers the allocation of the full year of sugar deliveries. The shipment's origin was Brazil, South America, and it was destined for Turkey. This inaugural transaction, negotiated and funded through our newly launched Trade Finance...

Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group

Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group

Nov 21, 2024

PITTSBURGH, November 21, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on innovative therapies for serious diseases with significant unmet needs, today announced the completion of dosing for the first cohort in its multi-center Phase 2a clinical trial of LP-310, a liposomal-tacrolimus oral rinse being developed for the treatment of Oral Lichen Planus (OLP). In this first cohort, eight...

LuxUrban Hotels Inc. Signs A Non-Binding Letter of Intent for Proposed Joint Venture with Lockwood Development Partners LLC and The Bright Hospitality Management to Elevate Hotel Operations and Guest Experience

LuxUrban Hotels Inc. Signs A Non-Binding Letter of Intent for Proposed Joint Venture with Lockwood Development Partners LLC and The Bright Hospitality Management to Elevate Hotel Operations and Guest Experience

Nov 20, 2024

Strategic initiative would provide LuxUrban with a $7 million initial capital infusion, offering the opportunity to broaden its market impact representing a key milestone in building Lux 2.0 Joint venture would leverage advanced technology integration to streamline operations, elevate service offerings, and deliver an enhanced guest experience MIAMI, November 20, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis,...

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

Nov 20, 2024

Additions of ProgenaMatrix®and revyve™ Antimicrobial Wound Gel part of planned expansion of BioStem’s commercial product portfolio POMPANO BEACH, Fla., November 20, 2024 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics, today announced the signing of a Letter of Intent (LOI) to acquire commercial-stage products and development technologies from ProgenaCare Global...

LuxUrban Hotels Inc. Signs A Non-Binding Letter of Intent for Proposed Joint Venture with Lockwood Development Partners LLC and The Bright Hospitality Management to Elevate Hotel Operations and Guest Experience

LuxUrban Hotels Inc. Reports Third Quarter 2024 Financial Results

Nov 20, 2024

MIAMI, November 20, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced its financial results for the third quarter ended September 30, 2024 (“Q3 2024”). The Company filed its quarterly report on Form 10-Q for Q3 2024 with the U.S. Securities and Exchange Commission on November 19, 2024 Q3 2024 Financial Overview: Net...

Premier Graphene Completes Joint Venture with Leading Technology and Systems Development Company Isatek S.A. de C.V.

Premier Graphene Completes Joint Venture with Leading Technology and Systems Development Company Isatek S.A. de C.V.

Nov 20, 2024

EL CENTRO, Calif., November 20, 2024 – PRISM MediaWire -Premier Graphene Inc. (OTC PINK: BIEI), formerly Premier Biomedical Inc., announced today the completion of a joint venture between publicly traded Premier Graphene and Isatek SA de CV and two other parties. With over three decades of operational growth, Isatek SA de CV is at the forefront of technology and systems development in Mexico. Isatek SA de CV is also a pioneer in the development of blockchain technology in Mexico. Founded by...

SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

SKYX to Participate in the 13th Annual ROTH Technology Conference in New York City November 19-20, 2024

Nov 18, 2024

MIAMI, Nov. 18, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today announced participation in the upcoming 13th Annual Roth Technology Conference to be held on November 19 - 20, 2024 at the Hard Rock...

SPZI: JP3E Commenced Initial Shipment for Sugar Commodity Contract

SPZI: JP3E Reports Significant Revenue Growth and Strong Consolidated Financial Results for Nine Months Ended September 30, 2024

Nov 18, 2024

Somerset, NJ, November 18, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (“JP3E”) formerly known as Spooz, Inc. (OTC: SPZI), a provider of innovative financial and commodity trading solutions, has announced its consolidated financial results for the nine months ended September 30, 2024. The results reflect strong revenue growth, strategic acquisitions, and operational efficiency, signaling a period of robust expansion and innovation for the company. Key Highlights for Consolidated Financials...

Ethical Web AI Appoints Peter Varnish OBE to Advisory Board

Ethical Web AI Appoints Peter Varnish OBE to Advisory Board

Nov 18, 2024

NEW YORK, NY, November 18, 2024 - PRISM MediaWire - Bubblr Inc., d/b/a Ethical Web AI (OTCQB: BBLR) - a frontrunner in ethical technology determined to revolutionize the digital domain, today announced it has appointed Peter Varnish OBE to its Advisory Board. Peter Varnish has built a career of outstanding achievement as an independent electronics and weapons engineer specializing in defence and security, and he advises corporations and governments on the latest threats, resilience, and...